Characteristics of subjects
| Group . | No. . | Age (mean) . | Time after Tx (mean, months) . | Rejections (no. patients) . | Rejection treatment . | CMV-reactivation* (no. patients) . | Positive urine cultures (no. patients) . |
|---|---|---|---|---|---|---|---|
| Controls | 13 | 42 | na | na | na | na | na |
| Transsectional RTx patients | 7 | 58 | 36, 5 | 2 | corticosteroids | 0 | 4 |
| Longitudinal RTx patients | 6 | 47 | 12 | 1 | corticosteroids | 0 | 2 |
| Group . | No. . | Age (mean) . | Time after Tx (mean, months) . | Rejections (no. patients) . | Rejection treatment . | CMV-reactivation* (no. patients) . | Positive urine cultures (no. patients) . |
|---|---|---|---|---|---|---|---|
| Controls | 13 | 42 | na | na | na | na | na |
| Transsectional RTx patients | 7 | 58 | 36, 5 | 2 | corticosteroids | 0 | 4 |
| Longitudinal RTx patients | 6 | 47 | 12 | 1 | corticosteroids | 0 | 2 |
CMV indicates cytomegalovirus; na, not applicable; RTx, renal transplantation; PCR, polymerase chain reaction.
As defined by positive PCR or 4-fold rise in specific antibody titer.